News & Events

Chinese partners bring strong potential to advance research at Biodesign Institute

January 3, 2018

ASU’s approach toward global research engagement addresses some of the most pressing problems facing us in health today—including global pandemics and a growing cancer incidence in the developing world—that are tied to issues that require multiple, transnational partners to come up with solutions more rapidly. Recently, ASU Biodesign Institute Executive Director Joshua LaBaer led a delegation to visit key Chinese partners to further explore new research possibilities. The stops...

Sugar-coated world

December 18, 2017

Sugar-coated world Glycans are essential to virtually every biological process in the body. These complex structures—composed of interlocking sugar molecules—adorn the surfaces of cells in fuzzy profusion. Glycans are a crucial part of a cell’s identity, helping it communicate with other cells and with the external environment. Glycans are also known to play a vital role in cancer, autoimmune disease and countless other afflictions. Despite their ubiquity and importance, glycans...

Biodesign researchers featured in breast cancer foundation's national campaign

October 18, 2017

The Breast Cancer Research Foundation funds more than 275 researchers across 15 countries and six continents. Biodesign Institute executive director Joshua LaBaer, M.D., Ph.D., was asked to play a prominent role in BCRF’s international awareness campaign. As a BCRF grant recipient, LaBaer was selected for his work in identifying genes that are especially important on particularly aggressive types of breast cancer – and for his personal advocacy for breast cancer research: LaBaer's own...

Discovery's Desert Home

September 18, 2017

  Editor's note: The following story was featured in the February 15 print edition of the journal Nature.  The Biodesign Institute at Arizona State University was designed to foster multidisciplinary collaboration and solve the world’s great challenges. The results speak for themselves. William Graves came to the Biodesign Institute at Arizona State University (ASU) determined to change the world. The physicist had spent the past 13 years at the Massachusetts Institute of...

ASU appoints Josh LaBaer, M.D., Ph.D., as new executive director

March 30, 2017

Arizona State University announced today that Joshua LaBaer, M.D., Ph.D., a leading researcher in cancer and personalized medicine, has been appointed the new executive director of the Biodesign Institute at Arizona State University, effective April 1, 2017. “Josh’s solutions-oriented research and innovative leadership make him uniquely qualified to guide the Biodesign Institute on its revolutionary path,” said Michael M. Crow, ASU president. “In many ways, Josh’s career trajectory...

New indicators to aid Crohn’s disease diagnosis and treatment

March 9, 2017

The diagnosis, understanding and management of Crohn’s disease may have just received a helping hand from a joint ASU Biodesign Institute and Mayo Clinic study aimed at developing a better blood test for the disease. The study, led by Biodesign scientists Josh LaBaer and Ji Qiu, along with gastroenterologists Shabana Pasha and Jonathan Leighton from Mayo Clinic Arizona, successfully identified several molecules, called biomarkers, that were unique indicators found only in patients with...

ASU Alumni Founders' Day to celebrate a pioneer in personalized medicine field

March 9, 2017

Editor’s Note: This story is one in a series of profiles of individuals being honored as part of the ASU Alumni Association’s 2017 Founders’ Day celebration on March 16. Visit the Alumni Association’s website to read the entire series.  Joshua L. LaBaer is being honored at Founders’ Day with the Faculty Research Achievement Award for his groundbreaking work in the emerging field of personalized medicine. He is the interim executive director of the Biodesign Institute...

Advancing the Most Innovative Institute at America’s Most Innovative University

February 23, 2017

Joshua LaBaer, M.D., Ph.D., Interim Executive Director, Biodesign Institute; Director, Biodesign Virginia G. Piper Center for Personalized Diagnostics Joshua LaBaer is one of the nation’s foremost investigators in the rapidly expanding field of personalized diagnostics. His efforts focus on the discovery and validation of biomarkers — unique molecular fingerprints of disease — which can provide early warning for those at risk of major illnesses, including cancer and diabetes. Formerly...

ASU chosen for team developing radiation-absorption test

October 17, 2016

  Arizona State University has been selected for a team that will complete development of a test that could save thousands of lives in the event of a nuclear explosion. The test is one of the first to be able to determine how much radiation has been absorbed by a person exposed to a radiological event. It is capable of testing thousands of people quickly. The U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response will fund...

Nimble Storage donation revs up big data science

August 31, 2016

To advance research discoveries, ASU scientists have to rely on faster and more reliable computing power and state-of-the-art number-crunching to handle all of their evergrowing big data computing, network and storage needs.  Now, Nimble Storage's advanced petabyte technology donation to ASU's Biodesign Institute will allow faster access to 'big data' research into early disease detection and cancer research. Recently, leadership from Biodesign and Nimble...